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Reovirus Type 3 clone 9 (T3C9)-induced lethal encephalitis is age dependent. We examined the effects of T3C9 inoculated
into neonatal and adult mice by intracerebral, intramuscular, or peroral routes and the effect of lipopolysaccharide (LPS) on
IL-1a levels in the blood and the brain. In parallel, we measured mice survival to T3C9 challenge, primary replication, and
growth in and spread to the brain. The results show that T3C9 infection increased IL-1a only in the brain of neonatal mice,
whereas LPS enhanced IL-1a in the brain and in the blood in both neonatal and adult mice. In neonatal mice, a T3C9-induced
IL-1a increase coincided with viral replication-induced nervous tissue injury and preceded death. Anti-IL-1a antibody partially
protected neonatal mice against T3C9 peroral challenge, further suggesting that this cytokine is involved in the mechanisms
leading to lethal encephalitis. In adult mice, T3C9 was not lethal and did not modify IL-1a levels although it slowly replicated
in nervous tissues when inoculated directly into the brain. Together, these results suggest that differences in nervous tissue
response to T3C9 replication between newborn and adult mice could account in part for the age-dependent susceptibility to
T3C9-induced lethal encephalitis. © 1999 Academic Press
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sINTRODUCTION
Mammalian reoviruses are nonenveloped viruses with
double-stranded RNA genome segmented into 10
enes. Three serotypes, represented by their prototypes,
ype 1 Lang (T1L), Type 2 Jones (T2J), and Type 3 Dear-
ng (T3D), have been identified by neutralization and
emagglutination-inhibition tests (Weiner and Fields,
977; Nibert et al., 1996). These viruses are ubiquitous in
heir capacity to infect nearly every known mammalian
pecies. Although there is no clear evidence relating
eoviruses to any known human diseases, the different
athologies observed in infected laboratory animals
ave provided very useful models of viral infection (Tyler
nd Fields, 1996). Susceptible hosts when inoculated
ith viral strains of the three serotypes present different
atterns of injury. Thus, T1L preferentially infects
pendymal cells resulting in hydrocephalus, whereas
erotype 3 reoviruses preferentially replicate in neurons
nducing lethal encephalitis, a phenotype mapped to the
iral S1 gene encoding the sigma 1 protein (Weiner et al.,
980; Tyler et al., 1985, 1986, 1989; see also Nibert et al.,
996 as a review). Stages in the pathogenesis of Type 3
eoviruses have been defined (Tyler et al., 1989; Virgin et
l., 1988). Detection of viral antigens by immunohisto-
1 To whom correspondence and reprint requests should be addressed
t current address: Department of Hematology and Oncology, Cornell
niversity Medical College, Room C-609, 1300 York Avenue, New York, NY
0021. Fax: (212) 746-8866. E-mail: mderrien@mail.med.cornell.edu.s† Deceased.
35hemistry at early times after inoculation of Type 3 reo-
irus into the footpad or into the gastrointestinal tract
llowed the identification of the kinetics of viral propa-
ation and the pathways taken by the virus to invade
ervous tissues. After injection of a lethal dose of T3D
nto the footpad, infected neurons in the spinal cord can
e detected as soon as 19 h after inoculation, and by day
postinfection, spinal cord, brain stem, and brain pre-
ented large foci of infection (Flamand et al., 1991). Re-
virus strain Type 3 Clone 9 (T3C9) was used to identify
tages of viral pathogenesis related to infection through
he gastrointestinal tract. T3C9 first replicated in the
ntestine, infecting preferentially mononuclear cells of
leal Peyer’s patches and neurons of the myenteric
lexus, before gaining access to the bloodstream and
erve terminals. Three to 4 days after inoculation, the
ppearance of viral antigen in the dorsal motor nucleus
f the vagus nerve (DMNV) before any detection in other
tructures of the brain suggested a direct spread of the
irus from the intestine through parasympathetic fibers of
he vagus nerve to the brainstem. Viral antigens were
ubsequently detected in other nuclei sending sensory
nd sympathetic fibers to the small intestine (Morrison et
l., 1991).
Little is known about the host humoral factors involved at
ach of these stages or about the mechanisms of resis-
ance to viral infection. Indeed, one interesting feature of
his pathogenesis is that mice develop resistance to infec-
ion with age. Type 3 reovirus growth in the intestine and
pread to extraintestinal tissues such as lymph nodes and
pleen were found to be age-restricted in mice (Kaufmann
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
e
r
l
S
i
s
s
T
o
T
t
c
f
c
i
w
l
T
i
s
n
e
1
1
d
t
t
f
v
(
a
i
r
t
i
F
m
m
d
r
a
q
d
i
s
E
g
i
n
d
o
1
F
p
p
T
W
f
o
f
r
a
d
D
s
i
s
h
u
t
l
b
m
s
d
p
n
t
i
P
m
d
n
a
c
m
c
i
t
c
m
i
t
b
l
t
a
o
s
i
u
u
t
m
i
36 DERRIEN AND FIELDSt al., 1983; Barkon et al., 1996). Similarly, the capacity of
eovirus Type 3 strains to replicate in neurons and to induce
ethal encephalitis is age-dependent (Tardieu et al., 1983).
tudies aiming to elucidate the host response to reovirus
nfection indicated that both competence of the immune
ystem and maturity of target tissues could determine the
usceptibility to reovirus infection. Under conditions where
3C9 induces lethal encephalitis (in neonatal mice per-
rally challenged with T3C9), depletion of CD41 and CD81
cells not only enhanced the pathology but also changed
he tissue tropism of the virus (Virgin and Tyler, 1991). In
ontrast, mature CD4 and CD8 T cells adoptively trans-
erred into neonatal mice protected against T3C9 peroral
hallenge by decreasing viral titers in the brain and the
ntestine (Virgin and Tyler, 1991). Interestingly, these cells
ere not effective in protecting mice intracerebrally inocu-
ated with Type 3 reovirus (Tardieu et al., 1983; Virgin and
yler, 1991), supporting the idea that in newborn mice,
ntrinsic maturity of nervous tissues also influences mice
usceptibility to reovirus-induced encephalitis.
Interleukin-1a (IL-1a), a cytokine produced predomi-
antly by activated macrophages and monocytes, is also
xpressed by microglia in the brain (Giulian and Corpuz,
993; Dinarello, 1992; Ban et al., 1992; Van Dam et al.,
992). Expression of IL-1 in the nervous system during
evelopment suggests that this cytokine could be a fac-
or influencing maturation processes of the nervous sys-
em (Giulian et al., 1988). Moreover, IL-1a could be a key
actor mediating the communication between the ner-
ous system and the immune system during infection
Berkenbosch et al., 1987). Inflammation of the intestine
nd of muscle has been described in newborn mice
nfected with Type 3 reovirus by peroral or intramuscular
outes, respectively. Neuronal injury-inducing inflamma-
ion of various areas of the brain was also observed in
nfected neonatal mice (Weiner et al., 1980, see Tyler and
ields, 1996, for review). In contrast, necrotic lesions with
icroglial reactions were absent in the brain of adult
ice intracerebrally inoculated with Type 3 reovirus (Tar-
ieu et al., 1983). Thus, IL-1a could be involved in reovi-
us-induced inflammatory responses at the periphery
nd/or in nervous tissues in newborn mice. Conse-
uently, IL-1 may also contribute to the mechanisms
efining age-dependent susceptibility to reovirus Type 3
nfection. In this study, we have investigated these pos-
ibilities.
RESULTS
ffect of T3C9 on mice survival and kinetics of T3C9
rowth and spread to the brain after intracerebral (ic),
ntramuscular (im), and peroral (po) inoculation in
eonatal and adult mice
The dose of reovirus inducing 50% of death [lethal
ose 50, (LD50)] depends on the route of challenge and
n the age and the strain of mice used (Flamand et al., P991; Morrison et al., 1991; Virgin et al., 1988; Derrien and
ields, in preparation). The strain of mice used in the
resent study (Swiss Webster) differs from that used
reviously (NIH Swiss). We therefore identified a dose of
3C9 that was invariably lethal in 1- to 2-day-old Swiss
ebster mice. We have used a dose of 106 plaque-
orming units (PFU) po, which reproducibly induced 100%
f death (Fig. 1A). Doses of 102 and 104 PFU were chosen
or inoculation by intracerebral and intramuscular routes,
espectively, to ensure 100% lethality (Fig. 1A). Figure 1A
lso shows that all the newborn mice injected im or ic
ied between the 8th and the 12th days after inoculation.
eath of neonatal mice perorally inoculated was delayed
ince they died between the 10th and the 15th days after
noculation. Irrespective of the route of inoculation, the
ame amounts of virus when used to infect adult mice
ad no effect on mice survival (Fig. 1A).
We next examined the kinetics of viral propagation
nder these conditions. Viral titers were determined at
he site of injection, i.e., the intestine for peroral inocu-
ation, the muscle for intramuscular inoculation, and the
rain for intracerebral inoculation in neonatal and adult
ice at different times after inoculation. To measure viral
pread from the intestine or the muscle to the brain, we
etermined viral titers in the brain of mice challenged
erorally and intramuscularly. Figure 1B shows that in
eonatal mice, originally inoculated with 102 PFU ic, viral
iters measured in the brain 2 days after intracerebral
noculation were 7 3 104 PFU and reached almost 109
FU when determined 7 days after inoculation. In adult
ice, T3C9, when inoculated directly into the brain at the
ose of 102 PFU, also replicated but more slowly than in
eonatal mouse brain since viral titers measured 7 days
fter inoculation were 105 PFU (Fig. 1B). In neonatal mice
hallenged with a dose of 104 PFU im, viral titers in the
uscle measured 7 days after inoculation were in-
reased by 4 logs. Moreover, 5 3 104 and 9 3 107
nfectious particles were detected in the brain of neona-
al mice 4 and 7 days, respectively, after intramuscular
hallenge (Fig. 1C), indicating that T3C9 replicated in the
uscle and spread to the brain. In adult mice, viral titers
n the muscle decreased with time (Fig. 1C) and viral
iters were below the limit of detection (25 PFU/ml) in the
rain (data not shown). In neonatal mice perorally chal-
enged with a dose of 106 PFU, viral titers measured in
he intestine did not change with time (Fig. 1D). At 7 days
fter challenge, the detection of 7 3 106 PFU in the brain
f perorally inoculated mice demonstrated that T3C9 had
pread from the intestine to the brain. In adult mouse
ntestine, T3C9 was almost cleared by 7 days after inoc-
lation (Fig. 1D) and viral titers in the brain were always
nder the limit of detection (data not shown). Together,
hese results show that in 1- to 2-day-old Swiss Webster
ice, T3C9 can be lethal for 100% of the mice when
noculated at a dose of 102 PFU ic, 104 PFU im, and 106FU po. The kinetics of survival showed that ic and im
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37IL-1a AND REOVIRUS TYPE 3 INFECTIONnoculated mice died within the same period of time
hile po inoculated mice died later. As expected in adult
ice, T3C9 was not lethal. Progressive clearance from
ntestinal and muscular tissue with no spread to the
rain was observed in adult mice perorally or intramus-
ularly challenged. Finally, a low rate of replication in the
rain subsisted in adult mice inoculated intracerebrally.
ffect of lipopolysaccharide (LPS) on IL-1a
xpression in the brain and the blood in adult and
eonatal mice
The goal of this work was to determine whether IL-1a
as a host factor involved in T3C9-induced lethal infec-
ion. To ensure that changes in IL-1a in the blood and the
rain of neonatal and adult mice could be detected, mice
ere treated with a lethal dose of LPS (100 mg ip) or
ehicle, and IL-1a was measured in the brain and the
lood. As expected, LPS induced a significant increase
n IL-1a in the blood (P , 0.05) and the brain (P , 0.01)
f adult mice 3 and 6 h after injection (Fig. 2, left).
imilarly, LPS treatment induced a significant increase in
L-1a in the blood (P , 0.05) and the brain (P , 0.01) in
eonatal mice (Fig. 2, right). This increase just preceded
ice death which occurred within the 24 h following LPS
njection (data not shown). These results confirm that in
eonatal and adult mice treated with LPS, IL-1a in-
reased rapidly in the blood and in the brain as previ-
usly described in many previous reports (Ban et al.,
992; Van Dam et al., 1992; Gatti and Bartfai, 1993; see
lso Rothwell, 1991; Dinarello, 1992, as reviews). More-
ver, these results indicate that under these experimen-
al conditions, changes of IL-1a in the blood and the
rain can be measured in both adult and neonatal mice.
s previously suggested, IL-1a detected in the brain of
PS-treated mice could originate from peripheral macro-
hages and leukocytes recruited to nervous tissues
nd/or from activated glia in the brain (Van Dam et al.,
992).
ffect of T3C9 infection in neonatal mice on IL-1a
xpression in the brain and the blood
We next tested the possibility that lethal infection with
he neurotropic reovirus T3C9 in neonatal mice could
erebrally (ic), intramuscularly (im), or perorally (po) inoculated. For viral
iter determination, neonatal and adult mice (n 5 4 to 7 mice from
ifferent litters, per treatment) were intracerebrally (102 PFU), intramus-
ularly (104 PFU), or perorally (106 PFU) challenged with T3C9. At the
ndicated time after inoculation, mice were sacrificed, organs were
issected, and viral titers were determined by standard plaque assay.
ata represent the mean 6 SEM of viral titers determined in neonatal
nd adult brain at different times after viral inoculation into the brain (B),
n neonatal and adult muscle and in neonatal brain at different times
fter viral inoculation into the muscle (C), and in neonatal and adult
ntestine and in neonatal brain at different times after viral inoculationFIG. 1. Effect of T3C9 on mice survival (A) and kinetics of T3C9
rowth and spread to the brain after intracerebral (B), intramuscular (C),
nd peroral (D) inoculation in neonatal mice and adult mice. Neonatal
ice (1- to 2-day-old mice, n 5 7 to 9 per treatment from different litters
orn the same day) or adult mice (6- to 7-week-old mice, n 5 5 per
reatment) were intracerebrally (102 PFU), intramuscularly (104 PFU), or
erorally (106 PFU) challenged with T3C9. Mice death was recorded
very day for 21 days. (A) The percentage of surviving mice as anto the intestine (D).
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38 DERRIEN AND FIELDSnvolve IL-1a. The amount of endogenous IL-1a was
easured in a blood sample and in the brain of infected
nd uninfected animals at different times after infection.
o investigate the possibility that this immune response
o T3C9 infection could differ as a function of the route of
noculation, we determined IL-1a levels during viral in-
ection of the gastrointestinal tract, the muscle, and the
rain. The results show that in neonatal mice, intracere-
ral inoculation of 102 PFU induced a time-dependent
ncrease in the amount of IL-1a in the brain (Fig. 3, left,
op histogram). IL-1a increase was first detected in the
rain at 48 h (2 days) after intracerebral inoculation (P ,
.05) and the magnitude of the increase was maximal by
and 7 days after challenge of the virus in the brain (P ,
.01). There was no significant difference between the
evel of IL-1a measured in the blood of infected mice and
he level of IL-1a measured in the blood of noninfected
ontrol mice (Fig. 3, left, bottom histogram). Injection of
04 PFU into the muscle also induced a time-dependent
ncrease in IL-1a in the brain. This increase was first
etected at 96 h (4 days) postinfection (P , 0.05) and
FIG. 2. Effect of LPS on IL-1a levels in the brain and in the blood in
dult and neonatal mice. One- to 2-day-old mice and 6- to 7-week old
ice from different litters (n 5 3 to 6) were injected intraperitoneally
ith 100 mg of LPS or PBS. Immediately (t 5 0), 3 h, and 6 h after the
njection, mice were sacrificed, a blood sample was collected, and the
rain was dissected. IL-1a was extracted from the tissues and the
mount of IL-1a determined by ELISA. Data represent the mean 6 SEM
f the amount of IL-1a (pg/ml) detected in the brain (top histograms)
nd in the blood (bottom histograms) of adult (left histograms) and
eonatal mice (right histograms) treated with LPS or PBS. w, P , 0.05;
w, P , 0.01 compared to control (t test).as maximal by day 6 postinoculation (P , 0.01) (Fig. 3, tenter, top histogram). As observed in neonatal mice
ntracerebrally challenged with T3C9, im injection of the
irus had no significant effect on the amount of IL-1a in
he blood, irrespective of the time after infection (Fig. 3,
enter, bottom histogram). In neonatal mice perorally
noculated with a dose of 106 PFU, the amount of IL-1a in
he brain remained comparable to the amount of IL-1a
etected in the brain of control mice for 6 days and
ncreased significantly (P , 0.05) the seventh day post-
noculation (168 h after challenge) (Fig. 3, right, top his-
ogram). Again, there was no significant difference be-
ween the amount of IL-1a in the blood of infected mice
nd the amount of IL-1a in the blood of uninfected
ontrol mice (Fig. 3, right, top histogram). Together these
esults show that in neonatal mice, T3C9 infection acti-
ates the expression of IL-1a in the brain but not in the
lood irrespective of the route of inoculation. The time at
hich this increase is detected depends on the route of
noculation.
ffects of neutralizing monoclonal anti-IL-1a
ntibodies on neonatal mice survival after T3C9
eroral challenge
To confirm that IL-1a participates in the processes
eading to lethal encephalitis in neonatal mice, we stud-
ed the effect of a neutralizing monoclonal anti-IL-1a
ntibody on mice surviving T3C9 infection. The peroral
oute, which is the natural route of reovirus infection, was
hosen for this experiment. Anti-IL-1a antibodies were
njected directly into the brain of perorally infected mice,
days after peroral challenge. The results illustrated in
ig. 4 show that under these experimental conditions,
bout 10% of the mice perorally challenged with T3C9 at
dose of 103 PFU survived (control mice) and anti-IL-1a
ntibodies protected almost 50% of the mice. These
esults suggest that neutralization of IL-1a in the brain
ncreases the percentage of mice surviving T3C9 peroral
hallenge.
ffect of T3C9 infection in adult mice on IL-1a
xpression in the brain and the blood
To investigate the possibility that age-dependent sus-
eptibility to reovirus infection could be related to a
ifference between adult and newborn mice immune
esponses to viral infection, we measured IL-1a in the
lood and brains of infected and uninfected adult mice.
rrespective of the time after inoculation, there was no
ifference between the level of IL-1a measured in the
rain of control adult mice and the level in IL-1a mea-
ured in the brain of adult mice challenged with 102 PFU
c, 104 PFU im, or 106 PFU po (Fig. 5, top histogram). The
ame results were obtained for the amount of IL-1a inhe blood (Fig. 5, bottom histogram).
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39IL-1a AND REOVIRUS TYPE 3 INFECTIONDISCUSSION
In this study, we presented several lines of evidence
ndicating that IL-1a could be one of the host factors
nvolved in reovirus T3C9-induced lethal encephalitis in
eonatal mice. (1) Lethal infection with this neurotropic
irus activated IL-1a levels in the brain, irrespective of
he route of inoculation (intracerebral, intramuscular, or
eroral). (2) High levels of IL-1a were detected in the
rain of neonatal mice just before death occurred,
hereas IL-1a levels were not significantly modified in
nfected adult resistant mice. (3) Neutralizing anti-IL-1a
ntibodies increased neonatal mice survival against
3C9 peroral challenge. It is interesting to note that
either primary replication in peripheral tissues nor entry
FIG. 3. Effect of intracerebral, intramuscular, and peroral inoculation
o 2-day-old mice (n 5 3 to 5 from different litters) in two independe
erorally (106 PFU) challenged with T3C9 or with sterile distilled wate
ample was collected, and the brain was dissected. IL-1a was extracte
epresent the mean 6 SEM of the amount of IL-1a (pg/ml) detected in
ice intracerebrally inoculated with 102 PFU (T3C9 ic) or control (DW ic
T3C9 im) or control (DW im) (middle histograms); and of neonatal m
istograms). w, P , 0.05; ww, P , 0.01 compared to control (t test).f the virus into nervous tissues was sufficient to trigger mL-1a expression in the brain or the blood and that the
L-1a level in the blood was not modified during the
ourse of infection. This last result is consistent with a
revious report showing that rabies virus, which also
referentially infects nervous tissues (Shankar et al.,
991), increased the cytokine levels in the brain without
odifying the expression of IL-1a in the blood (Mar-
uette et al., 1996).
In neonatal mice, analysis of the results provided in-
ormation about the mechanisms by which IL-1a levels
ere enhanced in response to viral infection. Compared
o LPS [which induced a rapid increase in IL-1a (3 and
h after treatment) in the blood and in the brain], T3C9
noculated at a dose of 102 PFU into the brain of newborn
9 on IL-1a level in the brain and in the blood in neonatal mice. One-
riments were intracerebrally (102 PFU), intramuscularly (104 PFU), or
At the indicated time after inoculation, mice were sacrificed, a blood
the tissues and the amount of the cytokine determined by ELISA. Data
in (top histograms) and in the blood (bottom histograms) of neonatal
istograms); of neonatal mice intramuscularly inoculated with 104 PFU
rorally inoculated with 106 PFU (T3C9 po) or control (DW po) (rightof T3C
nt expe
r (DW).
d from
the bra
) (left h
ice peice did not modify IL-1a levels before 48 h postinfec-
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40 DERRIEN AND FIELDSion. Comparative analysis of viral titers in the brain with
he kinetics of IL-1a expression shows that the onset of
L-1a increase coincided with a mean of 7 3 104 infec-
ious particles. Therefore, these results indicate that in
eonatal mice the presence of viral particles in the brain
id not activate IL-1a expression per se but that viral
eplication-induced cell damage within nervous tissues
nitiated the expression of the cytokine. The results ob-
ained in mice intramuscularly or perorally challenged
lso argue in favor of this hypothesis. Indeed, an in-
rease in IL-1a in the brain was detected only 4 days (96
pi) after footpad inoculation and was observed 7 days
168 hpi) postperoral injection. In both cases, the time
fter inoculation at which IL-1a was detected coincides
ith the time required for the virus to reach the brain and
eplicate following the different routes of injection. In
ice inoculated into the hindlimb footpad, large areas of
he brain and brainstem are infected by day 4 (Flamand
t al., 1991). In mice perorally inoculated with T3C9,
enetration of nervous tissue is delayed since viral an-
igens are observed initially in neurons of the dorsal
otor nucleus of the vagus nerve 4 days postinfection
ut massive infection of the brain occurs by day 6 to 7
Morrison et al., 1991).
FIG. 4. Effect of neutralizing monoclonal anti-IL-1a on mice survival
o T3C9 challenge. Mice belonging to the same litter were divided into
wo groups (n 5 7 per group). One group was intracerebrally inoculated
ith 7.5 mg of monoclonal antibodies on the sixth day after viral
hallenge, and the other group was treated with PBS following the
ame route of injection (control mice). T3C9 (103 PFU) was perorally
noculated to 1-day-old animals. Mice death was recorded every day
or 20 days. Data represent the percentage of control and anti-IL-1a
reated mice surviving T3C9 infection as a function of the time after
eroral inoculation.It is possible that in immature nervous tissue, secre- dion of IL-1a is not a direct product of infected neurons
ut a secondary effect of the inflammatory response to
nfection. In agreement with this hypothesis, a previous
tudy demonstrated that reovirus-induced destruction of
eural tissue produced extensive inflammation in the
rain (Tardieu et al., 1983). IL-1a detected in infected
ice brain could reflect a local reaction of microglia,
hich synthesize IL-1a (Rothwell, 1991; Guilian and Cor-
FIG. 5. Effect of intracerebral, intramuscular, and peroral inoculation
f T3C9 on IL-1a levels in the brain and in the blood in adult mice. 6-
o 7-week-old mice (n 5 3 to 5 from different litters) in two independent
xperiments were intracerebrally (102 PFU), intramuscularly (104 PFU),
r perorally (106 PFU) challenged with T3C9 or sterile distilled water
control mice). At the indicated time after inoculation, mice were sac-
ificed, a blood sample was collected, and the brain was dissected.
L-1a was extracted from the tissues and the amount of the cytokine
etermined by ELISA. Data represent the mean 6 SEM of the amount
f IL-1a (pg/ml) detected in the brain (top histogram) and in the blood
bottom histogram) of adult mice intracerebrally inoculated with 102
FU (T3C9 ic) or control (DW ic); of adult mice intramuscularly inocu-
ated with 104 PFU (T3C9 im) or control (DW im); and of adult mice
erorally inoculated with 106 PFU (T3C9 po) or control (DW po) at
ifferent times after viral challenge.
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41IL-1a AND REOVIRUS TYPE 3 INFECTIONuz, 1993), in response to T3C9-induced neuronal dam-
ge. The possibility that IL-1a expression by brain mi-
roglial cells could contribute to the pathogenesis re-
ated to other viruses such as rabies (Marquette et al.,
996), measles (Schneider-Schaulies et al., 1993), human
mmunodeficiency virus (Merrill and Martinez-Maza,
993), or coronavirus (Parra et al., 1997) has been previ-
usly considered and supports our hypothesis. It re-
ains possible that activated macrophages/leukocytes
ecruited to foci of infection contributed to increasing
L-1a in the brain of infected neonatal mice although we
ound that in vitro, T3C9 inoculation of neonatal or adult
eritoneal macrophages did not activate IL-1a produc-
ion while LPS did (data not shown).
The mechanisms whereby age confers resistance to
ype 3 reovirus infection have not been fully elucidated.
n this study, we observed differences in T3C9 growth as
function of age. In agreement with previous studies
Kaufmann et al., 1983; Barkon et al., 1996), infection of
he muscle and of the intestine was cleared in adult
mmunocompetent mice, but not in neonatal mice.
pread from peripheral tissues to the adult brain was not
etected, whereas high viral titers were measured in
eonatal mice brain when inoculated peripherally. Fi-
ally, our data showed that in both neonatal and adult
ice T3C9 inoculated directly into the brain replicated
ut viral replication and spread were attenuated in the
ature nervous system. Supporting this finding, a previ-
us study showed that in adult nervous tissue, although
ertain neuronal subpopulations may retain selective
ulnerability to reovirus infection, spread of reovirus Type
Dearing was attenuated (Tardieu et al., 1983). Interest-
ngly, these authors were unable to demonstrate a dif-
erence in the ability of newborn and adult central ner-
ous system to absorb reovirus Type 3 in vitro or a
hange in cellular receptor for reovirus Type 3 as the
nimal matures. They proposed that the age-dependent
esistance to reovirus Type 3 encephalitis could be re-
ated to an intrinsic resistance to viral replication by
euronal cells or nonneuronal cells (Tardieu et al., 1983).
o our knowledge, the molecular basis defining such an
ge-dependent resistance to reovirus infection remains
nclear. However, recent works by Dr. P. W. K. Lee’s
aboratory suggest that susceptibility to reovirus infec-
ion is related to the activity of the ras signaling pathway
Coffey et al., 1998). Age-dependent activity of this sig-
aling pathway in neurons or microglial cells might be
onsidered to explain the age-dependent susceptibility
o reovirus infection.
In this study, we found an age-dependent increase in
L-1a levels in response to T3C9 infection. Furthermore,
or a similar increase in viral replication in the brain of
dult and neonatal mice (from 102 to 105 PFU), only
eonatal mice brains expressed high levels of IL-1a. A
revious study demonstrated that the extent of microglialeactions in the brain of reovirus-infected mice is age- bependent (Tardieu et al., 1983). The present results
xtend this observation and further suggest that the
umoral response of brain cells to T3C9 infection is
ifferent in adult and neonatal mice. There are some
ndications that basal production and regulation of many
ytokines is age-dependent (Adkins et al., 1993; Cu-
umano et al., 1993). As observed here, previous works
howed that activated IL-1a production either by perito-
eal macrophages (Inamizu et al., 1985) or by astrocytes
nd neurons in the brain (Ho and Bloom, 1998) declines
ith age.
Age-dependent susceptibility of the nervous system to
any pathogens has been related to the maturity of the
lood–brain barrier (Tuomanen, 1994; Uno et al., 1997).
ecause IL-1a injected into the parenchyma or intracis-
ernally induced meningitis and blood–brain barrier in-
ury (Quagliarello et al., 1991; Anthony et al., 1997), it is
empting to speculate that IL-1a released during reovirus
nfection of the immature central nervous system could
ermeabilize the blood–brain barrier. This effect might
acilitate the entry of viral particules into the central
ervous system. However, the response of brain cells to
njury involves IL-1-mediated compensatory mecha-
isms. IL-1 can activate astrocytes promoting wound
ealing, astrogliosis (Rostworowski et al., 1997; Giulian
nd Lachman, 1985; Guilian and Corpuz, 1993), and do-
aminergic neuron sprouting (Ho and Bloom, 1998). We
peculate that microglia in neonates might be more
eactive to T3C9-induced injury and that immature astro-
ytes might not be able to compensate for the detrimen-
al effects related to the inflammatory reaction. In adult
ice, microglia might be less reactive and/or have a
ore efficient repair system. A previous finding that age
ifference in the susceptibility of the brain to HIV could
e related to differences in reactivity of glial cells to viral
roteins, which is also associated with IL-1a expression
Koka et al., 1995), further supports our hypothesis. In
nother experimental system exploring age dependency
f the central nervous system to viral infection, viral
pread was also progressively restricted with age (Czub
t al., 1992). In agreement with our hypothesis, these
uthors proposed that the degree of damage is a func-
ion of the level of central nervous system infection
chieved and depends on the capacity of the nervous
ystem to compensate for the damage.
In summary, this study shows that in the course of
ethal infection with reovirus T3C9, IL-1a levels are en-
anced in the brain but not in the blood. This increase
oincides with entry and replication of the virus in the
mmature central nervous system and precedes lethality.
rotection experiments using neutralizing monoclonal
nti-IL-1a antibodies confirm that IL-1a is involved in the
echanisms resulting in lethal encephalitis in neonatal
ice. In contrast, in adult resistant mice T3C9 has no
ffect on IL-1a expression. Because T3C9 replicates in
oth adult and neonatal brain but significantly modifies
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42 DERRIEN AND FIELDShe expression of IL-1a in neonatal tissue only, it is
ossible that adult and neonatal brain cells respond
ifferently to T3C9 infection. Such a mechanism could
ontribute to the age-dependent susceptibility to reovirus
nfection.
MATERIALS AND METHODS
irus and cells
Spinner-adapted mouse L929 (L) cells were grown in
ither suspension or monolayer cultures in Joklik modi-
ied Eagle’s minimal essential medium (Irvine Scientific,
anta Ana, CA) that was supplemented with 2.5% fetal
alf serum (Hyclone Laboratories, Logan, UT), 2.5% via-
le serum protein Ag sera (Biocell Laboratories, Carson,
A), 2 mM glutamine, 1 U of penicillin per milliliter, and
mg streptomycin (Irvine Scientific) per milliliter. Reovi-
us Serotype 3 Clone 9 (T3C9) (Rosen and Abinanti,
960), twice plaque-purified before use, was grown from
aboratory stocks and subsequently purified as de-
cribed previously (Furlong et al., 1988).
noculations and animals
Animals. Neonatal (1- to 2-day-old pups) Swiss Web-
ter mice and adult (6- to 7-week-old) Swiss Webster
ice (Taconic Farms, Inc.) were used in this study. Mice
ere maintained in accordance with the standard guide-
ines (Committee on Care and Use of Laboratory Ani-
als, 1985). Births were recorded twice a day. In different
ndependent experiments, several litters of 1- to 2-day-
ld pups were randomized and groups of equal numbers
ere made.
Virus. Freshly purified virions were diluted in sterile
iltered water (vehicle) just prior to use. Peroral inocula-
ions were performed in a 30-ml volume through a cath-
ter passed into the esophagus (Rubin and Fields, 1980).
iltered blue food dye (3 ml/ml) was added to viral sus-
ensions or vehicle to monitor the accuracy of peroral
noculations (in newborn mice). Intracerebral or intra-
uscular inoculations were performed using a Hamilton
yringe equipped with a 30-gauge sterile needle. T3C9
r vehicle was inoculated po at a dose of 106 6 0.9 PFU.
or ic and im inoculations, the inoculated doses were 102
20 and 104 6 1.2 PFU, respectively, in a 10-ml volume;
ontrol mice were injected with sterile filtered water
sing the same procedure. To study the effect of mono-
lonal antibodies on mice survival against T3C9 peroral
hallenge, each litter was divided into two groups and
onoclonal antibody was administered to half of the
itter; the other half was treated with sterile phosphate
uffer (PBS) (diluent of monoclonal antibodies) as an
nternal control within one litter. Mice were inoculated
ith a single dose (7.5 mg ic in 15 ml) of neutralizing
onoclonal hamster anti-mouse IL-1a (Genzyme, Cam-ridge, MA) or PBS (control), 6 days after peroral inocu- fation. This antibody recognizes the IL-1a precursor and
ecreted and membrane-associated forms of natural
ouse IL-1a and is highly specific (Fuhlbrigge et al.,
988). Furthermore, no detectable cross-reactivity was
bserved with mouse IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7,
M-CSF, TNFa, or IFNg.
Mice were challenged with T3C9 at a dose of 103 PFU
o [to ensure about 80% of lethality in 1-day-old control
ice as previously established in neonatal Swiss Web-
ter mice (Derrien and Fields, in preparation)]. Mice were
bserved daily for survival and the experiments termi-
ated 20 days postinfection. Lipopolysaccharide (from
almonella thyphimurium, Sigma) or vehicle (sterile
hosphate buffer saline) was intraperitoneally injected
nto adult and newborn mice at a dose of 100 mg.
issue collection and virus titer determination
At different times postinoculation, mice were sacri-
iced, and tissues (brain, gut, or muscle) were placed into
ials containing 1 ml sterile gelatin saline and frozen at
70°C. Samples were frozen and thawed twice prior to
isruption by sonication as previously described (Bodkin
nd Fields, 1989). Virus titers in tissues as well as inoculi
ere determined by a standard plaque assay (Tyler et al.,
985).
ndogenous IL-1a determination
At different times postinoculation or treatment with
PS, mice were sacrificed, and a blood sample (50 ml per
ouse) was collected, placed into a vial, and immedi-
tely frozen. Brains were dissected on ice, weighed, and
mmediately frozen. For IL-1a extraction, samples were
hawed and kept on ice. Ice-cold IL-1a extraction buffer
20 mM HEPES, pH 7.4; 0.1 mM EDTA; 1 mM PMSF) was
dded to the blood samples (100 ml/sample) and to the
rains at a final concentration of 1 g of tissue per milli-
iter. Tissues were disrupted by sonication, transferred to
n Eppendorf tube, and submitted to centrifugation
14,000 rpm, 30 min, 4°C). Supernatants were carefully
emoved from the pellet, diluted (1:1) with serum diluent
rovided with the interTest-1aX Mouse IL-1a ELISA kit
Genzyme) and assayed according to instructions (limit
f detection 15 pg/ml).
tatistical analysis
Data collected from different independent experiments
ere pooled together and analyzed by a one-way anal-
sis of variance followed by a Student’s t test.
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